Trials / Completed
CompletedNCT03156647
Alpha-synuclein Level in Saliva to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome
Alpha-synuclein Level in the Saliva as a Potential Diagnostic Aid to Differentiate Between Idiopathic Parkinson Disease and Iatrogenic Parkinsonian Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- —
Summary
The aim of this study is to determine whether a significant reduction in the total level of alpha-synuclein and significant increase in the oligomeric form of alpha-synuclein and therefore the ratio oligomeric:total alpha-synuclein occurs in patients with Parkinson disease compared to patients with drug-induced parkinsonian syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Level of alpha-synuclein | Test of levels of total and ratio total:oligomeric in saliva |
Timeline
- Start date
- 2017-03-01
- Primary completion
- 2020-07-16
- Completion
- 2020-07-16
- First posted
- 2017-05-17
- Last updated
- 2021-07-29
Locations
3 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03156647. Inclusion in this directory is not an endorsement.